CRCP
CRL icon

Copper Rock Capital Partners’s Charles River Laboratories CRL Stock Holding History

Copper Rock Capital Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$7.31M Sell
32,269
-25,793
-44% -$5.35M 2.47% 26
2020
Q2 		$10.1M Sell
58,062
-44,827
-44% -$7.15M 1.74% 30
2020
Q1 		$160K Sell
102,889
-3,498
-3% -$525K 1.57% 18
2019
Q4 		$16.3M Sell
106,387
-35,571
-25% -$4.93M 1.23% 49
2019
Q3 		$18.8M Sell
141,958
-45,563
-24% -$6.11M 1.68% 20
2019
Q2 		$26.6M Buy
187,521
+14,478
+8% +$1.96M 1.97% 10
2019
Q1 		$24.8M Sell
173,043
-10,399
-6% -$1.37M 1.8% 11
2018
Q4 		$20.5M Sell
183,442
-83,912
-31% -$10.5M 1.61% 22
2018
Q3 		$35.8M Sell
267,354
-12,171
-4% -$1.5M 2.21% 2
2018
Q2 		$31.1M Sell
279,525
-22,455
-7% -$2.43M 1.79% 11
2018
Q1 		$32.2M Sell
301,980
-2,576
-0.8% -$278K 1.93% 19
2017
Q4 		$33.4M Buy
304,556
+10,546
+4% +$1.15M 2.08% 18
2017
Q3 		$31.4M Sell
294,010
-10,163
-3% -$1.04M 2.1% 18
2017
Q2 		$30.9M Sell
304,173
-10,009
-3% -$921K 2% 20
2017
Q1 		$28.2M Buy
314,182
+75,516
+32% +$6.41M 1.78% 29
2016
Q4 		$18.2M Buy
238,666
+252
+0.1% +$19.1K 1.16% 53
2016
Q3 		$19.7M Sell
238,414
-2,201
-0.9% -$185K 1.28% 52
2016
Q2 		$19.8M Sell
240,615
-69,665
-22% -$5.74M 1.5% 37
2016
Q1 		$23.6M Sell
310,280
-1,747
-0.6% -$129K 2.02% 21
2015
Q4 		$25.1M Sell
312,027
-1,108
-0.4% -$79.9K 2.09% 19
2015
Q3 		$19.9M Sell
313,135
-1,466
-0.5% -$105K 1.68% 41
2015
Q2 		$22.1M Buy
314,601
+38,301
+14% +$2.83M 1.64% 40
2015
Q1 		$21.9M Buy
+276,300
New +$20.4M 1.79% 31

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Copper Rock Capital Partners's CRL Position: Q3 2020 in Review

Copper Rock Capital Partners reduced its Charles River Laboratories (CRL) stake by 44% in Q3 2020, selling an estimated $5.35M and leaving 32,269 shares worth $7.31M. The position accounts for 2.47% of the portfolio, ranked #26.

Copper Rock Capital Partners first reported a position in CRL in Q1 2015 and has held it in 23 quarters since. The position peaked at $35.8M in Q3 2018. 492 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

  • Copper Rock Capital Partners held 32,269 shares of Charles River Laboratories worth $7.31M as of Q3 2020.
  • Copper Rock Capital Partners sold 25,793 Charles River Laboratories shares in Q3 2020, an estimated $5.35M.
  • Charles River Laboratories made up 2.47% of Copper Rock Capital Partners's portfolio in Q3 2020, its #26 holding.
  • Copper Rock Capital Partners first reported a position in Charles River Laboratories in Q1 2015 and has held it in 23 quarters since.
  • Copper Rock Capital Partners's Charles River Laboratories position peaked at $35.8M in Q3 2018.
  • 492 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on Copper Rock Capital Partners's 13F filing for Q3 2020, filed 19 Oct 2020.